SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
115.296 0.02 (0.02%)

NAV as on 19 Dec, 2014

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Nov 28, 14)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 36.90 25.01
Dr Reddys Labs Pharmaceuticals 24.60 16.67
Lupin Pharmaceuticals 16.25 11.02
Divis Labs Pharmaceuticals 8.97 6.08
Glenmark Pharmaceuticals 8.77 5.94
Cipla Pharmaceuticals 7.82 5.30
Aurobindo Pharm Pharmaceuticals 7.35 4.98
Ipca Labs Pharmaceuticals 7.25 4.92
Natco Pharma Pharmaceuticals 5.44 3.69
Strides Arcolab Pharmaceuticals 4.30 2.91
Sector Allocation (Nov 28, 14)
  Sector   % 1-Year
High Low

Pharmaceuticals

98.16 99.20 96.68
Asset Allocation (%) (Nov 28, 14)
Class
%

Equity

98.16

Others / Unlisted

0.28

Debt

0.00

Mutual Funds

N.A

Money Market

1.84

Cash / Call

-0.29

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

64.72

Top 10

86.52
Sectors
%

Top 3

98.16
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.